Early Phase Trial Oversight Committee

Purpose
The Early Phase Trial Oversight Committee (EPTOC)  provides oversight for NRG Oncology's Phase I and non-randomized Phase II trials and for the safety lead-in components of protocols. 

Five committees have unique roles to guide, review and evaluate, and implement clinical trials in accordance with the group's strategic themes, strengths, and the research needs of the overall National Clinical Trials Network. These committees include the Research Strategy Committee, Protocol Operations Management Committee, Data Monitoring Committee, Early Phase Trial Oversight Committee, and the Group Executive Committee.

Working Groups

No active committee working groups.

Scientific Program

Early Phase Trial Oversight Committee Leadership

Chair

Debra Richardson

Vice Chair

Yeku Oladapo, MD
Core Committee Members

Rita Axelrod
Bradley Carthon
Jim Dignam
Stephanie Gaillard
Jyoti Mayadev
Roisin O'Cearbhaill
Michael Sill
Shannon Westin

NRG Operations Representatives
Sara McCartney
Sharon Hartson

Resources

Early Phase Trials Oversight Committee Charter

 

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.